During their structured dialog in the pre-application phase, manufacturers and notified bodies should agree on which evidence from previous applications can be reused.
This clarification is featured in a new answer contained in the Medical Device Coordination Group’s just-released fifth revision of its Q&A document on Requirements Relating To Notified Bodies,
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?